Bellevue Group Ag Esperion Therapeutics, Inc. Transaction History

Bellevue Group Ag

$6.38 Billion
Q1 2024

A detailed history of Bellevue Group Ag transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 9,944,064 shares of ESPR stock, worth $20.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

9,944,064

Previous 4,204,264 136.52%

Holding current value

$20.8 Million

Previous $12.6 Million 112.01%

% of portfolio

0.42%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $11.6 Million - $17.3 Million	5,739,800 Added 136.52%	9,944,064 $26.7 Million
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $3,840 - $7,160	-4,000 Reduced 0.1%	4,204,264 $4.12 Million
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $178,120 - $890,600	-122,000 Reduced 2.82%	4,208,264 $6.69 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $534,450 - $892,500	105,000 Added 2.49%	4,330,264 $27 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $54,500 - $81,300	-10,000 Reduced 0.24%	4,225,264 $28.3 Million

Q2 2022 Aug 11, 2022	SELL	$4.77 - $6.67 $304,803 - $426,213	-63,900 Reduced 1.49%	4,235,264 $26.9 Million
Q1 2022 May 13, 2022	SELL	$3.34 - $5.56 $734,800 - $1.22 Million	-220,000 Reduced 4.87%	4,299,164 $19.9 Million
Q2 2021 Aug 12, 2021	BUY	$19.4 - $28.71 $10.3 Million - $15.2 Million	530,000 Added 13.29%	4,519,164 $95.6 Million
Q1 2021 May 12, 2021	SELL	$25.12 - $36.89 $28.9 Million - $42.4 Million	-1,149,287 Reduced 22.37%	3,989,164 $112 Million
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $7.92 Million - $11.7 Million	-327,264 Reduced 5.99%	5,138,451 $134 Million
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $5.07 Million - $8.57 Million	162,580 Added 3.07%	5,465,715 $203 Million
Q2 2020 Aug 13, 2020	BUY	$30.04 - $51.31 $7.97 Million - $13.6 Million	265,245 Added 5.27%	5,303,135 $272 Million
Q1 2020 May 14, 2020	BUY	$27.44 - $73.84 $14.1 Million - $37.9 Million	512,880 Added 11.33%	5,037,890 $159 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $10 Million - $17 Million	283,549 Added 6.69%	4,525,010 $270 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $6.34 Million - $8.75 Million	184,050 Added 4.54%	4,241,461 $155 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $143 Million - $186 Million	3,561,864 Added 718.77%	4,057,411 $189 Million
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $1.75 Million - $2.33 Million	43,575 Added 9.64%	495,547 $19.9 Million
Q4 2018 Feb 12, 2019	BUY	$36.99 - $59.11 $2.22 Million - $3.55 Million	60,120 Added 15.34%	451,972 $20.8 Million
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $3.19 Million - $4.03 Million	78,332 Added 24.98%	391,852 $17.4 Million
Q2 2018 Aug 07, 2018	BUY	$36.2 - $76.4 $5.1 Million - $10.8 Million	140,800 Added 81.52%	313,520 $12.3 Million
Q1 2018 May 09, 2018	BUY	$65.94 - $80.76 $10.9 Million - $13.3 Million	164,920 Added 2114.36%	172,720 $12.5 Million
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $8,694 - $13,486	-200 Reduced 2.5%	7,800 $514,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,000	8,000 $370,000

Others Institutions Holding ESPR

# of Institutions

174

Shares Held

125M

Call Options Held

2.08M

Put Options Held

1.01M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $139M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Esperion Therapeutics, Inc. Transaction History